L3MBTL2 Activators
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) is a member of the MBT domain-containing protein family involved in chromatin organization and gene expression regulation. There are no known direct chemical activators for L3MBTL2. However, several compounds may influence the function of L3MBTL2 indirectly through related pathways or cellular processes. L3MBTL2 Activators represent a class of chemicals that can influence the function of L3MBTL2. These compounds can indirectly influence the function of L3MBTL2 through their effects on related cellular pathways.
Chemicals such as 5-Azacytidine, Trichostatin A, Vorinostat, Romidepsin, Entinostat, Valproic Acid, Mocetinostat, Panobinostat, Belinostat, JQ1, EPZ-6438, and UNC1999 can potentially influence L3MBTL2 function through their effects on chromatin organization and gene expression regulation. The effects of these chemicals on L3MBTL2 function are context-dependent and may vary based on the cellular environment and other biochemical parameters.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that could affect DNA methylation status, possibly influencing L3MBTL2's role in gene expression regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that could affect histone acetylation status, possibly influencing L3MBTL2's role in chromatin organization. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat is a histone deacetylase inhibitor that could affect histone acetylation status, possibly influencing L3MBTL2's function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid is a histone deacetylase inhibitor that could affect histone acetylation status, possibly influencing L3MBTL2's function. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat is a histone deacetylase inhibitor that could affect histone acetylation status, possibly influencing L3MBTL2's function. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is a histone deacetylase inhibitor that could affect histone acetylation status, possibly influencing L3MBTL2's function. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that could affect histone reader protein binding, possibly influencing L3MBTL2's function. | ||||||
EPZ005687 | 1396772-26-1 | sc-497734 | 2.5 mg | $380.00 | ||
EPZ-6438 is a histone-lysine N-methyltransferase inhibitor that could affect histone methylation status, possibly influencing L3MBTL2's function. | ||||||
AGI-6780 | 1432660-47-3 | sc-480257 | 2.5 mg | $330.00 | ||
UNC1999 is a histone-lysine N-methyltransferase inhibitor that could affect histone methylation status, possibly influencing L3MBTL2's function. | ||||||